VJHemOnc is committed to improving our service to you

ASH 2014 | Therapeutic monoclonal antibodies for multiple myeloma

VJHemOnc is committed to improving our service to you

Ola Landgren

At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Ola Landgren (Memorial Sloane Kettering Cancer Center, New York, NY) discusses the development of therapies with novel monoclonal antibodies in multiple myeloma, including antibodies that target CD38, CS1 and PD-1.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter